Article
Pro-inflammatory cytokines reduce human TAFI expression via tristetraprolin-mediated mRNA destabilisation and decreased binding of HuR.
Thrombosis and haemostasis - 1 Aug 2015
Komnenov D, Scipione C A, Bazzi Z A, Garabon J J W, Koschinsky M L, Boffa M B
Abstract excerpt
Thrombin activatable fibrinolysis inhibitor (TAFI) is the zymogen form of a basic carboxypeptidase (TAFIa) with both anti-fibrinolytic and anti-inflammatory properties. The role of TAFI in inflammatory disease is multifaceted and involves modulation both of specific inflammatory mediators as well as of the behaviour of inflammatory cells. Moreover, as suggested by in vitro studies, inflammatory mediators are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
